- Principal
- The initial amount of money on which interest, returns, or tax liabilities are calculated.
- Interest rate
- The percentage charged or earned per period on the principal, expressed as an annual rate unless stated otherwise.
- Compounding
- The process by which interest is added to the principal so that subsequent interest is earned on the combined amount.
- Present value
- The current worth of a future sum, discounted at a given rate to account for the time value of money.
- IP royalty rate
- A key concept referenced by the IP Royalty Rate: Calculate IP licensing royalty rates using the 25% rule of thumb (licensor receives 25% of pretax profit), industry comparables, and the Georgia-Pacific factors. Covers software (6-12%), pharmaceutical (2-8%), and technology (3-7%) royalty benchmarks.
- Patent licensing royalty
- A key concept referenced by the IP Royalty Rate: Calculate IP licensing royalty rates using the 25% rule of thumb (licensor receives 25% of pretax profit), industry comparables, and the Georgia-Pacific factors. Covers software (6-12%), pharmaceutical (2-8%), and technology (3-7%) royalty benchmarks.
- Trademark royalty
- A key concept referenced by the IP Royalty Rate: Calculate IP licensing royalty rates using the 25% rule of thumb (licensor receives 25% of pretax profit), industry comparables, and the Georgia-Pacific factors. Covers software (6-12%), pharmaceutical (2-8%), and technology (3-7%) royalty benchmarks.
- Technology royalty rate
- A key concept referenced by the IP Royalty Rate: Calculate IP licensing royalty rates using the 25% rule of thumb (licensor receives 25% of pretax profit), industry comparables, and the Georgia-Pacific factors. Covers software (6-12%), pharmaceutical (2-8%), and technology (3-7%) royalty benchmarks.
- Georgia-Pacific factors
- A key concept referenced by the IP Royalty Rate: Calculate IP licensing royalty rates using the 25% rule of thumb (licensor receives 25% of pretax profit), industry comparables, and the Georgia-Pacific factors. Covers software (6-12%), pharmaceutical (2-8%), and technology (3-7%) royalty benchmarks.